Division of Astellas Pharma Inc.
Latest From Prosidion Ltd.
Plus news on recent financings by Vivus, Novira Therapeutics, Theraclone Sciences and Receptos.
To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup
PharmAsia News takes a closer look at pipeline updates from Japan’s two largest pharma companies.
To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup (Part 1)
In part one of this roundup of the Japanese pharma earnings season, PharmAsia News takes a closer look at the pipeline updates from the country's two largest pharma companies.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.
- Therapeutic Areas
- Metabolic Disorders
- Western Europe
- Parent & Subsidiaries
- Astellas Pharma Inc.
- Senior Management
Pierre Legault, Pres. & CEO
Lars Christiansen, Dir, Bus. Dev.
Mikael S Thomsen, PhD, VP, Dev.
- Contact Info
Phone: (44) 1865 782600
Oxford, OX4 6LT
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.